Zafgen Announces FDA Partial Clinical Hold On Obesity Trials
October 16, 2015 at 13:30 PM EDT
Shares of Zafgen are down 32% today after the FDA announced a partial clinical hold on the company's obesity trials.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |